Eflornithine
Edina Avdic, Pharm.D.
,
Paul A. Pham, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Eflornithine (IV): no longer commercially available in the U.S.
Treatment of unwanted facial hair in women (topical cream)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
African trypanosomiasis (sleeping sickness):
Second-stage
T. b. gambiense
Eflornithine is not effective against
T. b. rhodesiense
(East African form of the diseases)
Drug can be obtained from CDC by contacting the Division of Parasitic Diseases and Malaria (telephone, 404-718-4745; email,
parasites@cdc.gov
).
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2023 Unbound Medicine, Inc. All rights reserved